Silex Microsystems (SILEX) investor relations material

Executive summary

• Achieved strong growth and profitability in Q2 2026, with net sales up 27.3% year-over-year, supported by a successful IPO on Nasdaq Stockholm and the acquisition agreement for a U.S. fab.

• Expansion initiatives in the U.S. and Sweden are progressing, increasing production capacity by 35% and unlocking new business opportunities, including in defense and life sciences.

• Customer demand remained robust, especially in data centers for optical switches, telecom, and consumer electronics.

• Entered agreement to acquire a semiconductor facility in Pennsylvania, USA, for $40 million, supporting long-term growth strategy.

• Raised SEK 1 billion in IPO, strengthening the financial platform for expansion.

Financial highlights

• Q2 net sales reached SEKm 393, up 27.3% year-over-year; currency-adjusted growth was 31.8%.

• Q2 EBIT was SEKm 134, with a margin of 34.0%, up from 18.1% year-over-year; adjusted EBIT margin was 34.5%.

• Q2 net profit was SEKm 105, up 181.3% year-over-year; EPS after dilution rose to SEK 0.94 from SEK 0.42.

• Operating cash flow for Q2 was SEKm 123, with cash and equivalents at SEKm 1,305 at period end.

• Rolling 12-month net sales were SEKm 1,510, with a 32.2% EBIT margin.

Outlook and guidance

• Targeting SEKm 2.5 billion in net sales by 2030 and maintaining EBIT margin above 30% in the medium term.

• U.S. fab expected to reach EBIT break-even by 2029/2030 and achieve Sweden-like margins by 2034.

• No specific forecast for H2, but business expected to continue at a similar growth angle.

• Strong order inflow and customer interest, especially in telecom and life sciences.